Even With A 27% Surge, Cautious Investors Are Not Rewarding Windlas Biotech Limited's (NSE:WINDLAS) Performance Completely
Jun 07
Indian (NIFTY) Life Sciences Industry Analysis
UpdatedJun 11, 2024
DataAggregated Company Financials
Companies15
- 7D5.0%
- 3M18.6%
- 1Y23.2%
- YTD11.8%
The Life Sciences industry is up 5.0% in the last week, with Divi's Laboratories up 5.0%. This means that the industry has gained 23% over the past year. Looking forward, earnings are forecast to grow by 22% annually.
Industry Valuation and Performance
Has the Indian Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 11 Jun 2024 | ₹1.7t | ₹194.7b | ₹21.5b | 33.1x | 80.2x | 8.9x |
| Thu, 09 May 2024 | ₹1.4t | ₹168.0b | ₹18.7b | 29.3x | 77x | 8.6x |
| Sat, 06 Apr 2024 | ₹1.4t | ₹168.5b | ₹18.6b | 28.6x | 76.7x | 8.5x |
| Mon, 04 Mar 2024 | ₹1.4t | ₹168.5b | ₹18.6b | 32.5x | 73.4x | 8.1x |
| Wed, 31 Jan 2024 | ₹1.4t | ₹166.5b | ₹18.9b | 30.4x | 72.4x | 8.2x |
| Fri, 29 Dec 2023 | ₹1.4t | ₹155.9b | ₹18.1b | 21.9x | 78.8x | 9.1x |
| Sun, 26 Nov 2023 | ₹1.4t | ₹155.9b | ₹18.1b | 22.6x | 77x | 8.9x |
| Tue, 24 Oct 2023 | ₹1.3t | ₹156.1b | ₹19.8b | 23.9x | 65.2x | 8.3x |
| Thu, 21 Sep 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 24.5x | 71.8x | 9.1x |
| Sat, 19 Aug 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 26.6x | 70.2x | 8.9x |
| Mon, 17 Jul 2023 | ₹1.4t | ₹156.5b | ₹23.0b | 31.3x | 59.7x | 8.8x |
| Wed, 14 Jun 2023 | ₹1.3t | ₹157.2b | ₹23.0b | 28x | 56.5x | 8.3x |
| Fri, 12 May 2023 | ₹1.2t | ₹163.0b | ₹28.6b | 33.7x | 43.5x | 7.6x |
| Sun, 09 Apr 2023 | ₹1.1t | ₹159.5b | ₹28.4b | 32.4x | 38.6x | 6.9x |
| Tue, 07 Mar 2023 | ₹1.1t | ₹159.5b | ₹28.4b | 31.5x | 37.7x | 6.7x |
| Thu, 02 Feb 2023 | ₹1.2t | ₹166.4b | ₹34.5b | 29.8x | 34.7x | 7.2x |
| Sat, 31 Dec 2022 | ₹1.2t | ₹164.9b | ₹34.5b | 30.9x | 35.5x | 7.4x |
| Mon, 28 Nov 2022 | ₹1.2t | ₹164.9b | ₹34.5b | 29.7x | 35.3x | 7.4x |
| Wed, 26 Oct 2022 | ₹1.3t | ₹164.1b | ₹36.1b | 35.7x | 35.4x | 7.8x |
| Fri, 23 Sep 2022 | ₹1.3t | ₹162.5b | ₹35.7b | 37.3x | 35.4x | 7.8x |
| Sun, 21 Aug 2022 | ₹1.3t | ₹162.6b | ₹35.8b | 37.1x | 36.4x | 8x |
| Tue, 19 Jul 2022 | ₹1.3t | ₹158.3b | ₹34.2b | 33.4x | 38.7x | 8.4x |
| Thu, 16 Jun 2022 | ₹1.3t | ₹158.3b | ₹34.2b | 32.1x | 36.8x | 7.9x |
| Sat, 14 May 2022 | ₹1.4t | ₹149.7b | ₹30.1b | 32.9x | 47.4x | 9.5x |
| Mon, 11 Apr 2022 | ₹1.6t | ₹148.3b | ₹29.4b | 39.4x | 53x | 10.5x |
| Wed, 09 Mar 2022 | ₹1.4t | ₹148.3b | ₹29.4b | 33.8x | 47.4x | 9.4x |
| Fri, 04 Feb 2022 | ₹1.5t | ₹138.5b | ₹24.5b | 38.8x | 60.2x | 10.7x |
| Sun, 02 Jan 2022 | ₹1.6t | ₹137.8b | ₹24.6b | 34.1x | 65.1x | 11.6x |
| Tue, 30 Nov 2021 | ₹1.7t | ₹137.6b | ₹24.4b | 30.2x | 67.8x | 12x |
| Thu, 28 Oct 2021 | ₹1.7t | ₹132.1b | ₹22.7b | 22.9x | 73.7x | 12.6x |
| Sat, 25 Sep 2021 | ₹1.7t | ₹131.1b | ₹22.9b | 23.8x | 73.7x | 12.9x |
| Mon, 23 Aug 2021 | ₹1.6t | ₹131.4b | ₹22.9b | 21.7x | 70x | 12.2x |
| Sat, 10 Jul 2021 | ₹1.5t | ₹127.1b | ₹22.6b | 36.9x | 65.2x | 11.6x |
Price to Earnings Ratio
65.2x
Current Industry PE
- Investors are optimistic on the Indian Life Sciences industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 80.2x which is higher than its 3-year average PE of 56.7x.
- The industry is trading close to its 3-year average PS ratio of 9.1x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 15% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Indian Healthcare industry?
| IN Market | -0.18% | |
| Healthcare | 4.67% | |
| Life Sciences | 5.03% | |
| Clinical Research and Equipment | 5.03% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DIVISLAB Divi's Laboratories | ₹4.54k | 5.0% +₹56.9b | 31.9% | PE87x | |
| SYNGENE Syngene International | ₹710.30 | 6.7% +₹17.7b | -3.5% | PE55.4x | |
| INDGN Indegene | ₹550.30 | 3.3% +₹4.0b | n/a | PE36.4x | |
| DCAL Dishman Carbogen Amcis | ₹163.43 | 6.2% +₹1.5b | 25.2% | PS1x | |
| 530239 Suven Life Sciences | ₹98.16 | 6.8% +₹1.4b | 65.2% | PS183.1x |
